Suplatast tosilate

Suplatast tosilate
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code none
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 94055-76-2 YesY
PubChem (CID) 71773
UNII C9J89787U1 N
KEGG D01423 YesY
ChEMBL CHEMBL115435 N
ECHA InfoCard 100.220.132
Chemical and physical data
Formula C23H33NO7S2
Molar mass 499.64 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Suplatast tosilate (INN) is a Th2 cytokine inhibitor[1] which is used as an antiallergic drug. Often used in the treatment of Kimura's disease.[2][3]

References

  1. Tamaoki J, Kondo M, Sakai N, et al. (July 2000). "Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group". Lancet. 356 (9226): 273–8. doi:10.1016/S0140-6736(00)02501-0. PMID 11071181.
  2. Ueda T, Arai S, Amoh Y, Katsuoka K (2011). "Kimura's disease treated with suplatast tosilate and loratadine". European Journal of Dermatology. 21 (6): 1020–1. doi:10.1684/ejd.2011.1539. PMID 21914581.
  3. Tsukagoshi H, Nagashima M, Horie T, et al. (December 1998). "Kimura's disease associated with bronchial asthma presenting eosinophilia and hyperimmunoglobulinemia E which were attenuated by suplatast tosilate (IPD-1151T)". Internal Medicine. 37 (12): 1064–7. doi:10.2169/internalmedicine.37.1064. PMID 9932643.

Further reading


This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.